Skip to Main Content

Editor’s note: A recording of this conversation is embedded below. 

Eli Lilly was the first company to enter clinical trials with a drug designed to treat Covid-19. The medicine, a monoclonal antibody, will be tested for both treating and preventing infection in patients who have been exposed to the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!